European Journal of Pediatrics

, Volume 150, Issue 5, pp 325–326 | Cite as

Autosomal recessive chronic granulomatous disease associated with 18q- syndrome and end-stage renal failure due to Henoch-Schönlein nephritis

  • J. Kimpen
  • R. Van Damme-Lombaerts
  • G. Van den Berghe
  • W. Proesmans


Chronic granulomatous disease (CGD) is an inherited disorder in which phagocytes, including polymorphonuclear neutrophils, are unable to generate oxygen-derived microbicidal compounds, among them superoxide [1]. Two main types of CGD are known, an X-linked form which is normally associated with the absence of cytochromeb558, a component of the membrane-associated reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase which generates superoxide and an autosomal recessive form, in which cytochromeb558 is present, caused by the deficiency of a cytosolic factor required to activate NADPH oxidase [4]. Patients with the X-linked type are highly susceptible to infections; those with the autosomal recessive form may be less severely affected [10]. We report the unusual association of autosomal CGD with 18q- syndrome in a girl who developed terminal renal insufficiency caused by Henoch-Schönlein nephritis, and speculate on the possibility that the gene defect of autosomal recessive CGD may be located on chromosome 18.

Key words

Chronic granulomatous disease 18q Syndrome Henoch-Schönlein nephritis 



chronic granulomatous disease


nicotinamide adenine dinucleotide phosphate, reduced


nitroblue tetrazolium test


polymorphonuclear neutrophils


  1. 1.
    Babior BM, Crowley CA (1983) Chronic granulomatous discase and other disorders of oxidative killing. In: Stabury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds) The metabolic basis of inherited disease. McGraw-Hill, New York, pp 1956–1985Google Scholar
  2. 2.
    Bolscher BGJM, Zwieten R van, Kramer IJM, Weening RS, Verhoeven AJ, Roos D (1989) A phosphoprotein ofM r47.000, defective in autosomal chronic granulomatous disease, copurifies with one of two soluble components required for NADPH: O2 oxidoreductase activity in human neutrophils. J Clin Invest 83:757–763Google Scholar
  3. 3.
    Corbeel L, Boogaerts M, Van den Berghe G, Everaerts MC, Marchal G, Eeckels R (1983) Haematological findings in type Ib glycogen storage disease before and after portacaval shunt. Eur J Pediatr 140:273–275Google Scholar
  4. 4.
    Curnutte JT (1988) Classification of chronic granulomatous disease. Hematol Oncol Clin North Am 2:241–252Google Scholar
  5. 5.
    DeChatelet LR, Shirley PS (1981) Evaluation of chronic granulomatous disease by a chemiluminescence assay of microliter quantities of whole blood. Clin Chem 27:1739–1741Google Scholar
  6. 6.
    Jones KL (1988) Smith's recognizable patterns of human malformation, 4th edn. Saunders, Philadelphia, pp 58–59Google Scholar
  7. 7.
    McKusick VA (1989) Mendelian inheritance in man, 8th edn. John's Hopkins University Press, Baltimore, pp 1302–1305Google Scholar
  8. 8.
    Schinzel A, Hayashi K, Schmid W (1975) Structural aberrations of chromosome 18. The 18q-Syndrome. Report of three cases. Humangenetik 26:123–132Google Scholar
  9. 9.
    Van Rhenen DJ, Koolen MI, Feltkamp-Vroom ThM, Weening RS (1979) Immune complex glomerulonephritis in chronic granulomatous disease. Acta Med Scand 206:233–237Google Scholar
  10. 10.
    Weening RS, Adriaansz LH, Weemaes CMR, Lutter R, Roos D (1985) Clinical differences in chronic granulomatous disease in patients with cytochrome b-negative or cytochrome b-positive neutrophils. J Pediatr 107:102–104Google Scholar
  11. 11.
    Wertelecki W, Gerald PS (1971) Clinical and chromosomal studies of the 18q- syndrome. J Pediatr 78:44–52Google Scholar

Copyright information

© Springer-Verlag 1991

Authors and Affiliations

  • J. Kimpen
    • 1
  • R. Van Damme-Lombaerts
    • 1
  • G. Van den Berghe
    • 1
  • W. Proesmans
    • 1
  1. 1.Department of Paediatrics, University Hospital GasthuisbergUniversity of LeuvenLeuvenBelgium

Personalised recommendations